Biopsy tools are the instruments used by surgeons, radiologists, and other medical professionals to identify inflammatory or cancerous diseases. These tools are used to stop artifacts from being crushed and tissue fragmentation. As a result, they are frequently used to perform MRI-guided, core & vacuum-assisted, and needle-based biopsies of various body parts because they are lightweight and highly sensitive.
The rising preference for less invasive procedures, an increase in cancer cases globally, and government initiatives for diagnosis are the driving forces behind the growth of the biopsy devices market. Breast, skin, and prostate cancer have all been extensively diagnosed using biopsies, which have been one of the main diagnosis methods for cancer disorders. According to a report released by the World Health Organization (WHO) on April 3rd, 2003, the number of new cases of cancer could reach 15 million by the year 2020, representing a further 50% rise in cancer rates.
According to Marketlook Consulting’s research report “Global Biopsy Devices market Analysis, 2021”, the Global Biopsy Devices market is anticipated to grow at a CAGR of 8.5% during 2022-29 The market would reach USD 3.8 Bn by 2029.
Based on Product Type, the primary categories for biopsy devices are biopsy forceps, aspiration biopsy needles, and needle-based biopsy instruments like guns, etc. the needle-based biopsy grabbed the major market share and dominated the market in 2021. Emerging number of patients of gastrointestinal tract disease, cancer etc., is contributing to the growth of this segment.
Based on End-User Type, biopsy devices are predominantly used in hospitals and clinics to diagnose cancerous diseases as well as in academic and research institutions for study purposes.
“Global Biopsy Devices market Analysis, 2021” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for Biopsy Device providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.
Request for Sample:- https://marketlookconsulting.com/sample-request/16
North America Dominated the Market
Based on Leading regions, North America dominated the global Biopsy Devices market in 2021 and is projected to maintain its dominance during the forecasted period 2022-29 as the United States is found to perform the most biopsies, which contributes to the growth of the market as a whole. According to projections from the American Cancer Society, there will be about 60,650 new cases of all types of leukemia and 24,000 leukemia-related deaths in the United States in 2022. Additionally, over the anticipated timeframe, the development of sophisticated healthcare infrastructure and the rising incidence of infections will favorably affect the market for biopsy devices in the forthcoming period as stated in the Marketlook Consulting research report “Global Biopsy Devices market Analysis, 2021”.
According to Marketlook Consulting’, the key players with a considerable market share in the global Biopsy Devices market are Medtronic plc, Olympus Corporation, Cardinal Health, Inc B. Braun Melsungen AG, Argon Medical Devices, Leica Biosystems, Devicor Medical Products, Inc., Cook Group Incorporated, Becton, Dickinson, and Company, C. R. Bard, Inc.
Read More:- https://marketlookconsulting.com/reports/biopsy-devices-market
Market Segmentation:
- By Product Type (Needle based Biopsy guns, Biopsy Needles, Biopsy Forceps, Others)
- By End Users (Hospitals and clinics, Academic and Research institutes)
- By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa)
- By Company (Medtronic plc, Olympus Corporation, Cardinal Health, Inc B. Braun Melsungen AG, Argon Medical Devices, Leica Biosystems, Devicor Medical Products, Inc., Cook Group Incorporated, Becton, Dickinson, and Company, C. R. Bard, Inc.)
Key questions answered in the study:
- What are the current and future trends of the Biopsy Device industry?
- How the industry has been evolving in terms of end-user demand and product advancements?
- How the competition has been shaping across the countries followed by their comparative factorial indexing?
- What are the key growth drivers and challenges for the Biopsy Device industry?
- What is the customer orientation, purchase behavior, and expectations from the Biopsy Device firms across various regions?
About Us:-
Marketlook Consulting is a world market intelligence and consulting firm that aims to offer business insights and market research reports to large as well as small & medium scale enterprises (SMEs). The company helps its clients to design business strategies and policies and accomplish sustainable growth in their relevant market area.
Contact US:-
Phone:- +91 9660950683
Name:- Mithun Jangir (Manager- Marketing & Communications)
Email:- [email protected]
LinkedIn:- https://www.linkedin.com/company/marketlook-consulting
U 26C/6, DLF Phase 3, Gurgaon 122002
According to a new market research report Biopsy Devices Market by Product (Core Needle Biopsy, Aspiration Biopsy, Vacuum Assisted Biopsy) Application (Breast Biopsy, Lung Biopsy, Prostate Biopsy) Guidance (Stereotactic, Ultrasound) & by End User (Hospital) - Global Forecast to 2022, published by MarketsandMarkets™, the market is expected to reach USD 2.42 Billion by 2022 from an estimated USD 1.74 Billion in 2017, at a CAGR of 6.8% during the forecast period.Browse 180 Market Data Tables and 42 Figures spread through 219 Pages and in-depth TOC on "Biopsy Devices Market"Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=132886515 The Report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.Factors such as rising prevalence of cancer, increasing preference for minimally invasive surgeries, and initiatives undertaken by governments & global health organizations are the major factors driving the growth of this market.By product, the needle-based biopsy instruments segment accounted for the largest share of the marketOn the basis of product, the needle-based biopsy instruments segment accounted for the largest share of the global biopsy devices market in 2016.
This can be attributed to the preference of needle-based biopsies over open surgical biopsies and increasing preference for minimally invasive surgeries.The lung biopsy segment is expected to highest growth during the forecast periodBased on application, the lung biopsy segment accounted for the largest share of the biopsy devices market.
Additionally, the availability of funding for lung cancer research is contributing to the growth of this market segment.The ultrasound-guided biopsy segment dominated the market in 2016Based on guidance technique, the ultrasound-guided biopsy segment accounted for the largest share of the biopsy devices market.
This quick and simple procedure offers advantages, such as no ionizing radiation exposure, low complication rate, and lower cost as compared to other biopsy techniques.The hospitals segment held the highest CAGR during the forecast periodBased on end user, the hospitals segment is expected to register the highest growth rate during the forecast period.
The strong financial capabilities of hospitals and the presence of trained professionals are the major factors supporting the rising adoption of biopsy devices among hospitals.North America dominated the market in 2016North America accounted for the largest share of the biopsy devices market in 2016, followed by Europe.
The rising prevalence of cancer, government initiatives to spread awareness about cancer, favorable reimbursement scenario for biopsy devices in the U.S., and the presence of key players in the region are the key factors driving the growth of the biopsy devices market in North America.Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=132886515 The major players in the biopsy devices market are C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), INRAD, Inc. (U.S.), and Medtronic plc (Ireland).About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
